R-RPLND as First-line Treatment for Clinical Stage IIA/B Testicular Seminoma
R-RPLND as First-line Treatment for Clinical Stage IIA/B Testicular Seminoma
Recruiting · NCT05345158 · Registry updated 2025-12-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| R-RPLND as First-line Treatment for Clinical Stage IIA/B Testicular Seminoma | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, germinoma, neoplasm, seminoma | Recruiting | Not applicable | 2025-12-19 | NCT05345158 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University Health Network, Toronto | 417 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Princess Margaret Cancer Centre | Toronto | Canada | 145 |